Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993110priorityCriticalpatent/ECSP993110A/en
Publication of ECSP993110ApublicationCriticalpatent/ECSP993110A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Un método para regular la actividad in vivo del sustrato es útil para el tratamiento de trastornos médicos como ser la inflamación, arteriosclerósis y angiogénesis. El método involucra la administración de una cantidad efectiva de in inhibidor de DPP-IV a un paciente que necesita de dicho tratamiento.A method of regulating substrate activity in vivo is useful for the treatment of medical disorders such as inflammation, arteriosclerosis, and angiogenesis. The method involves administering an effective amount of a DPP-IV inhibitor to a patient in need of such treatment.
ECSP9931101999-08-201999-08-20
REGULATION OF SUBSTRATE ACTIVITY
ECSP993110A
(en)